Type 1 Diabetes (update)
NICE in development [GID-CGWAVER122] Anticipated publication date: August 2015
Consultation
Type 1 Diabetes (update): guideline consultation
A clinical practice guideline on Type 1 Diabetes update is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations. Individuals and organisations not registered as stakeholders are not able to comment. We recommend that you register as a stakeholder or contact the registered stakeholder organisation that most closely represents your interests and pass your comments to them.
Note that the provisional recommendations presented here do not constitute the Institute's formal guidance on this topic. The recommendations are provisional and may change after consultation.
An embargoed version of the final guideline will be available to stakeholder organisations that comment during this consultation. Stakeholders must respond to the consultation in order to receive a confidentiality form to sign. The response needn’t be formal comments, an email to say ‘no comment’ will suffice. Respondents will receive a confidentiality form after the consultation closes.
The embargoed version will be released two weeks before the official publication and will be subject to the signing of the confidentiality form. Only stakeholder organisations that return a signed confidentiality form (signed by hand, not electronically) returned either by email or post will receive the embargoed guideline 2 weeks before the official publication.
Consultation dates: 10 December 2014 – 4 March 2015
http://www.nice.org.uk/guidance/indevelopment/gid-cgwaver122/consultation
A long document but should be of interest to Type1 diabetics.
NICE in development [GID-CGWAVER122] Anticipated publication date: August 2015
Consultation
Type 1 Diabetes (update): guideline consultation
A clinical practice guideline on Type 1 Diabetes update is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations. Individuals and organisations not registered as stakeholders are not able to comment. We recommend that you register as a stakeholder or contact the registered stakeholder organisation that most closely represents your interests and pass your comments to them.
Note that the provisional recommendations presented here do not constitute the Institute's formal guidance on this topic. The recommendations are provisional and may change after consultation.
An embargoed version of the final guideline will be available to stakeholder organisations that comment during this consultation. Stakeholders must respond to the consultation in order to receive a confidentiality form to sign. The response needn’t be formal comments, an email to say ‘no comment’ will suffice. Respondents will receive a confidentiality form after the consultation closes.
The embargoed version will be released two weeks before the official publication and will be subject to the signing of the confidentiality form. Only stakeholder organisations that return a signed confidentiality form (signed by hand, not electronically) returned either by email or post will receive the embargoed guideline 2 weeks before the official publication.
Consultation dates: 10 December 2014 – 4 March 2015
http://www.nice.org.uk/guidance/indevelopment/gid-cgwaver122/consultation
A long document but should be of interest to Type1 diabetics.
